CNS Leaders Forum

CNS Leaders Forum

June 15-16 2021 | Virtual | Eastern Timezone

Connecting CNS Decision Makers for Accelerated Therapeutic Success

Registration Agenda

Partners

Knowledge Partners
Knowledge Partner

Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

Learn More

CNS LEADERS FORUM IN A NUTSHELL
Target CNS
PURPOSE

The CNS Leaders Forum exists to provide the meeting point for the CNS industry to discuss end-to-end treatment options and how to accelerate them into the hands of patients with unmet neurological needs. With current treatments often failing in development, the time to think more holistically is now!

Graduation CNS.
LEARNING OPPORTUNITIES

Driven by novel case studies and strategic discussions, The CNS Leaders Forum will provide a broad array of insights and guidance from those breaking the mould in treatment development. Hear about how visionaries are working on the future breakthroughs in drug development, tech and more.

CNS Convergence
CONVERGENCE

Designed specifically for decision makers from pharma, digital health, biotech, academia, investors and more, The CNS Leaders Forum will serve as a hot-bed of cross-disciplinary idea sharing and collaboration opportunities. It will take a village (and more) to move the needle and deliver the next-generation of treatments.

Speaker Faculty

Adele Diamond
Adele Diamond
Canada Research Chair Tier 1, Professor of Developmental Cognitive Neuroscience
The University of British Columbia
Adele Diamond
Canada Research Chair Tier 1, Professor of Developmental Cognitive Neuroscience
The University of British Columbia
Brent Vaughan
Brent Vaughan
Chief Executive Officer
Cognito Therapeutics
Brent Vaughan
Chief Executive Officer
Cognito Therapeutics
Innes Meldrum
Innes Meldrum
SVP & Chief Commercial Officer
Otsuka Pharmaceutical North America
Innes Meldrum
SVP & Chief Commercial Officer
Otsuka Pharmaceutical North America

Innes Meldrum is SVP & Chief Commercial Officer at Otsuka Pharmaceuticals USA. Innes leads commercial success of Otsuka’s North American business which includes Neuroscience, Nephrology, and Digital products. Innes oversees Commercial Strategy and Commercial Operations including Market Access, Training and Development, Sales and Marketing Operations, as well as Business Insights and Strategy.

Francesca Cormack
Francesca Cormack
Director of Research & Innovation
Cambridge Cognition
Francesca Cormack
Director of Research & Innovation
Cambridge Cognition

Francesca is Director of Research and Innovation at Cambridge Cognition. She has extensive experience of statistics, cognitive neuroscience and cognitive test development in a range of clinical populations. Since joining Cambridge Cognition in 2014, Francesca has worked to develop novel cognitive testing methodology to support high-frequency, near patient testing using digital technology, providing researchers and healthcare providers with unique insights into cognitive health.

Francesca obtained a PhD in Dementia with Lewy Bodies at Newcastle University, followed by post-doctoral and academic positions at University College London and at the Medical Research Council in Cambridge. She maintains academic collaborations focused on neurological disorders, ageing and dementia

Donna Walsh
Donna Walsh
Executive Director
European Federation of Neurological Associations
Donna Walsh
Executive Director
European Federation of Neurological Associations
Mads Daalsgard
Mads Daalsgard
SVP, Head of Experimental Medicine & Clinical Development
Lundbeck
Mads Daalsgard
SVP, Head of Experimental Medicine & Clinical Development
Lundbeck
Ryan Field
Ryan Field
Chief Technology Officer
Kernel
Ryan Field
Chief Technology Officer
Kernel
Natasha Hussein
Natasha Hussein
Scientific Director, Kavli Neuroscience Discovery Institute
John Hopkins University & School of Medicine
Natasha Hussein
Scientific Director, Kavli Neuroscience Discovery Institute
John Hopkins University & School of Medicine
Ray Dorsey
Ray Dorsey
Professor of Neurology, Director, CHET
University of Rochester Medical Center
Ray Dorsey
Professor of Neurology, Director, CHET
University of Rochester Medical Center
Magdalene Moran
Magdalene Moran
President & CSO
Caraway Therapeutics
Magdalene Moran
President & CSO
Caraway Therapeutics
Pavan Choksi
Pavan Choksi
Venture Partner
Arkitekt Ventures
Pavan Choksi
Venture Partner
Arkitekt Ventures
Ciara Clancy
Ciara Clancy
Founder & CEO
Beats Medical
Ciara Clancy
Founder & CEO
Beats Medical
Tiago Fleming Outeiro
Tiago Fleming Outeiro
Director of the Department of Experimental Neurodegeneration
University Medical Center Gottingen
Tiago Fleming Outeiro
Director of the Department of Experimental Neurodegeneration
University Medical Center Gottingen
Lana Ghanem
Lana Ghanem
Managing Director
Hikma Ventures
Lana Ghanem
Managing Director
Hikma Ventures
Laurence Barker
Laurence Barker
Partner & Chief Business Officer
Dementia Discovery Fund
Laurence Barker
Partner & Chief Business Officer
Dementia Discovery Fund
Fransisco Jurado
Fransisco Jurado
Chief Scientific Officer
Neuraxpharm
Fransisco Jurado
Chief Scientific Officer
Neuraxpharm
Sabrina Paganoni
Sabrina Paganoni
Co-Director
MGH Neurological Clinical Research Institute
Sabrina Paganoni
Co-Director
MGH Neurological Clinical Research Institute
Liam Kaufman
Liam Kaufman
Co-Founder & CEO
Winterlight Labs
Liam Kaufman
Co-Founder & CEO
Winterlight Labs
Kate Rosenbluth
Kate Rosenbluth
Founder & CSO
Cala Health
Kate Rosenbluth
Founder & CSO
Cala Health
Anish Shindore
Anish Shindore
Head of Neurotech & Open Innovation
Biogen
Anish Shindore
Head of Neurotech & Open Innovation
Biogen
Mikael Eliasson
Mikael Eliasson
Global Head of Innovation, Neuroscience
Genentech
Mikael Eliasson
Global Head of Innovation, Neuroscience
Genentech
Adam Koppel
Adam Koppel
Managing Director
Bain Capital
Adam Koppel
Managing Director
Bain Capital
Paola Barbarino
Paola Barbarino
Chief Executive Officer
Alzheimers Disease International
Paola Barbarino
Chief Executive Officer
Alzheimers Disease International
Kim Baden-Kristensen
Kim Baden-Kristensen
Co-Founder & CEO
Brain+
Kim Baden-Kristensen
Co-Founder & CEO
Brain+
Newton Howard
Newton Howard
Professor of Computational Neuroscience & Neurosurgery
Nuffield Department of Scientific Surgery, University of Oxford
Newton Howard
Professor of Computational Neuroscience & Neurosurgery
Nuffield Department of Scientific Surgery, University of Oxford
Stacie Weninger
Stacie Weninger
President
F-Prime Capital
Stacie Weninger
President
F-Prime Capital
Eddie Martucci
Eddie Martucci
Co-Founder & CEO
Akili Interactive
Eddie Martucci
Co-Founder & CEO
Akili Interactive
Ken Kramer
Ken Kramer
AVP, Global Therapeutic Area Lead, Neuroscience
AbbVie
Ken Kramer
AVP, Global Therapeutic Area Lead, Neuroscience
AbbVie

Our Mission

The current treatment of CNS disorders is leaving unprecedented unmet medical needs for patients suffering from neurological conditions. Over the past few years, there have been minimal advancements in drug development and it’s becoming clear that in order to deliver for patients, it will need a convergence of all stakeholders to provide more holistic treatment options. 

The inaugural CNS Leaders Forum will provide the platform for leaders from every corner of the industry to learn, share and collaborate in order to create a streamlined, patient-centric approach in tackling CNS disorders.

Constructed by the pioneers of the industry, this meeting is set to mold the future of CNS therapeutics development and position patients central in our endeavours.

The time for the future of CNS treatments is now!

Agenda +
Our Mission

Partnerships

The CNS Leaders Forum being online presents an opportunity for us to super-charge our offering. We have selected the best-in-class platform to offer our attendees a wide range of options to learn, network, and collaborate. The result, bringing together more senior R&D and business exec’s from across the industry.

Making your session engaging and knowledgeable will attract the largest audience.  We will guide you on how best to maximize the benefits of using our platform.

No need to sit behind a desk!  Our networking tools enable attendees to arrange 121 video conversations as well as taking part in curated networking sessions. You could potentially meet many more people than you would in a typical venue setting.

Get in touch to learn more about the options available.

Contact Us +
Partnerships

Register for the Event

For pricing and booking options please click the button to go to the registration page.

Registration